Dense breast tissue and mammography: why supplemental screening is now federally required disclosure

Dense breast tissue both increases cancer risk and reduces mammogram sensitivity — a double effect that new federal notification rules are built around.

Breast density — the proportion of fibroglandular tissue relative to fatty tissue, categorized on a standard scale from mammography reports — has a specific double effect worth understanding: dense tissue is independently associated with higher breast cancer risk, and it also appears white on mammography just as many cancers do, which reduces the sensitivity of standard mammography specifically in dense-breasted women.

This combination — higher risk and a screening test that's less effective at detecting cancer in that same population — is the basis for a federal requirement, now in effect nationally, that mammography facilities notify patients of their breast density category and inform them that dense tissue can mask cancer on a mammogram, prompting a conversation about supplemental screening options.

Supplemental options discussed for dense-breasted women include breast MRI or ultrasound, with the appropriate choice depending on overall risk profile (family history, genetic factors) alongside density category — a decision that's specific enough to warrant a direct conversation with a radiologist or breast specialist rather than a one-size answer, since supplemental screening also carries its own false-positive tradeoffs.

This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.

More in Cancer Screening & Prevention

Lung cancer screening guidelines: who qualifies for low-dose CT Colorectal cancer screening age changes explained The difference between screening and diagnostic tests

Dense breast tissue and mammography: why supplemental screening is now federally required disclosure

Dense breast tissue both increases cancer risk and reduces mammogram sensitivity — a double effect that new federal notification rules are built around.

This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.